Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR positive SARS-CoV-2 infection including drug induced changes in the corrected QT interval (QTc)
Samuel et al., Heart Rhythm, doi:10.1016/j.hrthm.2020.06.033
Samuel et al., Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR.., Heart Rhythm, doi:10.1016/j.hrthm.2020.06.033
Jul 2020   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
In pediatric patients with PCR positive active COVID-19 infection, significant arrhythmias are infrequent, but occur at an incidence higher than expected in a general pediatric population. Comorbidities are not more common in patients with arrhythmias than in patients without arrhythmias. However, providers still need to be vigilant for comorbidities that may independently place patients at risk for arrhythmias. COVID-19 treatment using HCQ leads to significant QTc prolongation, but was not associated with arrhythmias in pediatric patients. The long term sequelae of arrhythmia development in this population and their impact on outcome needs to be studied.
Samuel et al., 1 Jul 2020, peer-reviewed, 7 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: Journal Pre-proof INCIDENCE OF ARRHYTHMIAS AND ELECTROCARDIOGRAPHIC ABNORMALITIES IN SYMPTOMATIC PEDIATRIC PATIENTS WITH PCR POSITIVE SARS-CoV-2 INFECTION INCLUDING DRUG INDUCED CHANGES IN THE CORRECTED QT INTERVAL (QTc). Sharmeen Samuel, MD, Richard A. Friedman, MD, Chetan Sharma, MD, Madhusudan Ganigara, MD, Elizabeth Mitchell, MD, Charles Schleien, MD, Andrew D. Blaufox, MD. PII: S1547-5271(20)30632-9 DOI: https://doi.org/10.1016/j.hrthm.2020.06.033 Reference: HRTHM 8462 To appear in: Heart Rhythm Received Date: 9 June 2020 Revised Date: 25 June 2020 Accepted Date: 29 June 2020 Please cite this article as: Samuel S, Friedman RA, Sharma C, Ganigara M, Mitchell E, Schleien C, Blaufox AD, INCIDENCE OF ARRHYTHMIAS AND ELECTROCARDIOGRAPHIC ABNORMALITIES IN SYMPTOMATIC PEDIATRIC PATIENTS WITH PCR POSITIVE SARS-CoV-2 INFECTION INCLUDING DRUG INDUCED CHANGES IN THE CORRECTED QT INTERVAL (QTc)., Heart Rhythm (2020), doi: https://doi.org/10.1016/j.hrthm.2020.06.033. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Published by Elsevier Inc. on behalf of Heart Rhythm Society. INCIDENCE OF ARRHYTHMIAS AND ELECTROCARDIOGRAPHIC ABNORMALITIES IN SYMPTOMATIC PEDIATRIC PATIENTS WITH PCR POSITIVE SARS-CoV-2 INFECTION INCLUDING DRUG INDUCED CHANGES IN THE CORRECTED QT INTERVAL (QTc). Running Title: CARDIAC ELECTROPHYSIOLOGIC FINDINGS ASSOCIATED WITH PEDIATRIC COVID-19. 1,2 Sharmeen Samuel MD, 1,2 Richard A Friedman MD, 1,2 Chetan Sharma MD, 1,2 Madhusudan Ganigara MD, 1,2 Elizabeth Mitchell MD, 1Charles Schleien MD, 1,2 Andrew D Blaufox, MD. Affiliation of authors 1 Section of Pediatric Cardiology 2 Departments of Pediatrics Cohen Children’s Medical Center, Northwell Health System Donald and Barbara Zucker School of Medicine at Hofstra University Address of correspondence Sharmeen Samuel, MD. Division of Pediatric Cardiology 1111 Marcus Ave, 4B New Hyde Park, NY 11042 Fax no: (516) 601-7380 Email address: ssamuel21@northwell.edu CONFLICTS OF INTEREST: None WORD COUNT: 4913 ABSTRACT: 1 Background: There is limited data regarding the electrophysiological abnormalities and arrhythmias in children with COVID-19, including those associated with treatment using potentially pro-arrhythmic Hydroxychloroquine (HCQ) and Azithromycin (AZN). Objectives: To describe the electrophysiologic findings and arrhythmias associated with pediatric COVID-19 and its treatment. Methods: A single center retrospective chart review was undertaken and included all patients with 1) symptoms of COVID-19, and 2) PCR (+) nasopharyngeal swabs for SARS-CoV-2 who were placed on continuous telemetry for the duration of their hospitalization during March through May, 2020. Results: Thirty-six patients were included in the study. Significant arrhythmias were found in 6 (nonsustained (ns) ventricular tachycardia in 5 and sustained atrial tachycardia in 1). All were self-resolving and half prompted prophylactic anti-arrhythmic therapy. Patients..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit